Henry Schein (HSIC): financials, SEC filings and peers
Henry Schein (HSIC) is a health care distributors company in the Health Care sector of the S&P 500, headquartered in Melville, New York.
It was founded in 1932 and joined the S&P 500 on March 17, 2015.
Its fiscal year ends in December, and its shares trade on the Nasdaq.
In its SEC filings it is classified as “Wholesale-Medical, Dental & Hospital Equipment & Supplies”.
Henry Schein at a glance
- Revenue (12 months)
- $13.7B
- Revenue growth
- +6.2%
- Operating margin
- 5.2%
- Net income (12 months)
- $421M
- Free cash flow (12 months)
- $559M
- Cash
- $184M
- Debt
- $3.5B
- Diluted EPS (12 months)
- $3.65
Twelve months to September 26, 2026, from the 10-Q filed November 3, 2026.
Latest twelve months
Over the twelve months to September 26, 2026, Henry Schein reported revenue of $13.7 billion, about the same as a year earlier (+6.2%).
Its operating margin was 5.2%: for every $100 of sales, about $5 was left as operating profit.
Net income was $421 million (3.1% of revenue), 7.7% higher than a year earlier.
Operating cash flow was $687 million and capital spending $128 million, leaving free cash flow of $559 million (4.1% of revenue).
At the end of the period it held $184 million in cash and $3.5 billion in debt, a net debt position of $3.3 billion.
The diluted share count fell 7.0% in a year, typically the result of buybacks.
Five-year trend
- Revenue went from $10.1 billion in fiscal 2020 to $13.2 billion in fiscal 2025, about 5.4% a year.
- Operating margin has been steady, around 5.0%.
- Free cash flow was positive in each of the last 6 fiscal years.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $12.4B | $12.6B | $12.3B | $12.7B | $13.2B |
| Revenue growth | 22.6% | 2.0% | -2.4% | 2.7% | 4.0% |
| Operating margin | 6.9% | 5.9% | 5.0% | 4.9% | 5.0% |
| Net income | $631M | $538M | $416M | $390M | $398M |
| Free cash flow | $631M | $506M | $353M | $700M | $573M |
| Diluted EPS | $4.45 | $3.91 | $3.16 | $3.05 | $3.27 |
Fiscal years as reported in Henry Schein’s 10-K filings. Free cash flow is operating cash flow minus capital spending.
Recent SEC filings
- 10-Q filed November 3, 2026 — quarterly report
- 8-K filed November 3, 2026 — Earnings results
- 8-K filed October 8, 2026 — Executive or director change; Regulation FD disclosure
- 8-K filed September 22, 2026 — Material agreement; New debt obligation
- 10-Q filed August 4, 2026 — quarterly report
- 8-K filed August 4, 2026 — Earnings results
- 8-K filed July 30, 2026 — Executive or director change; Regulation FD disclosure
- 8-K filed May 22, 2026 — Shareholder vote results; Regulation FD disclosure
Companies like Henry Schein
Other S&P 500 companies in Health Care Distributors:
- CAHCardinal HealthDublin, Ohio
- CORCencoraConshohocken, Pennsylvania
- MCKMcKesson CorporationIrving, Texas
More from Health Care
Questions about Henry Schein
Is Henry Schein's revenue growing?
Yes. Revenue for the twelve months to September 26, 2026 was $13.7 billion, up 6.2% from a year earlier, according to its SEC filings.
Is Henry Schein profitable?
Yes. It earned $421 million in net income over the twelve months to September 26, 2026, a net margin of 3.1%.
Does Henry Schein have more cash or more debt?
At September 26, 2026 it had $184 million in cash and $3.5 billion in debt, so more debt than cash.
When did Henry Schein last file financial results?
Its latest quarterly report (10-Q) was filed with the SEC on November 3, 2026.
Which companies are similar to Henry Schein?
In the S&P 500, Henry Schein is grouped in Health Care Distributors within the Health Care sector. Cardinal Health (CAH), Cencora (COR), McKesson Corporation (MCK) are in the same group.
Understand the numbers
Source: Henry Schein’s filings with the U.S. Securities and Exchange Commission (EDGAR), retrieved November 10, 2026. Figures are as reported by the company and may be restated. This page is for information only and is not financial advice.